Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 26037941

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2015 Aug 1
First author
Long GV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2015 Aug 1;386(9992):410-2. doi: 10.1016/S0140-6736(15)60972-2.
    note
    Source null
    related pmid
    26037942
    relationship
    Comment in

Authors and identifiers

  1. name
    Long GV
    type
    Author
  2. name
    Stroyakovskiy D
    type
    Author
  3. name
    Gogas H
    type
    Author
  4. name
    Levchenko E
    type
    Author
  5. name
    de Braud F
    type
    Author
  6. name
    Larkin J
    type
    Author
  7. name
    Garbe C
    type
    Author
  8. name
    Jouary T
    type
    Author
  9. name
    Hauschild A
    type
    Author
  10. name
    Grob JJ
    type
    Author
  11. name
    Chiarion-Sileni V
    type
    Author
  12. name
    Lebbe C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Long GV
    type
    Author
  2. name
    Stroyakovskiy D
    type
    Author
  3. name
    Gogas H
    type
    Author
  4. name
    Levchenko E
    type
    Author
  5. name
    de Braud F
    type
    Author
  6. name
    Larkin J
    type
    Author
  7. name
    Garbe C
    type
    Author
  8. name
    Jouary T
    type
    Author
  9. name
    Hauschild A
    type
    Author
  10. name
    Grob JJ
    type
    Author
  11. name
    Chiarion-Sileni V
    type
    Author
  12. name
    Lebbe C
    type
    Author
bibliography ids
  1. nci-bib-300c4af828f1fb391b91655f
book metadata
content sha256
a4802de7e08d7d7cf12289ad0a2c6f98bd494cc27a2dedf8197faf4ae2cd01f6
document type
citation
dois
  1. 10.1016/S0140-6736(15)60898-4
electronic publication date
display
2015 May 31
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26037941
immutable id
pubmed:26037941@a4802de7e08d7d7cf12289ad0a2c6f98bd494cc27a2dedf8197faf4ae2cd01f6
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9992
name
Lancet (London, England)
nlm unique id
2985213R
pages
444-51
volume
386
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2015 Aug 1;386(9992):410-2. doi: 10.1016/S0140-6736(15)60972-2.
    note
    Source null
    related pmid
    26037942
    relationship
    Comment in
outcomes validated
false
pmid
26037941
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
0d6a0df129d002f7c881ef367198e723d335b25675cbbfd50f25e77533681986
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Aug 1
precision
day
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26037941/
title
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.

Preserved source evidence · Independent clinical review pending · Not medical advice